Loading...
XHKG0286
Market cap40mUSD
Dec 23, Last price  
1.62HKD
1D
1.89%
1Q
16.55%
Jan 2017
-92.92%
Name

COMMON SPLENDOR INTL HLTH INDSTRY GP LTD

Chart & Performance

D1W1MN
XHKG:0286 chart
P/E
—
P/S
0.56
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
10.87%
Rev. gr., 5y
8.02%
Revenues
555m
-21.15%
4,698,0003,512,0002,812,0006,790,0009,099,0008,483,0008,410,0008,370,00010,407,000359,818,000530,948,999554,962,000474,933,000377,035,000619,189,000620,363,000663,235,000703,354,000554,581,000
Net income
-177m
L+7.32%
7,092,0004,819,00015,193,000-4,854,00011,788,000-1,859,00013,094,000-11,585,0009,052,00027,505,00034,009,00042,096,0001,422,0002,160,00011,237,000-381,352,0005,300,000-165,324,000-177,421,000
CFO
83m
+134.36%
-90,000-756,000-71,635,000-53,988,000-53,988,000-1,153,000-1,663,000-5,030,000-79,493,000-81,936,000130,648,000-124,444,000-49,672,00040,562,000-36,848,000-102,361,00041,013,00035,283,00082,691,000
Dividend
Jun 22, 20200.00067 HKD/sh
Earnings
Mar 26, 2025

Profile

Aidigong Maternal & Child Health Limited, an investment holding company, provides postpartum care and healthcare services in the People's Republic of China and Hong Kong. It operates through Postpartum Care Services, Health Industry, and Other segments. The company offers maternal and child healthcare services; medical anti-aging services; healthcare industry investment services; and healthcare property development services, as well as trades in natural health food and pharmaceutical products. It also offers precision life healthcare, bio-medical technology, and management services, as well as investment and finance services. The company was formerly known as Common Splendor International Health Industry Group Limited and changed its name to Aidigong Maternal & Child Health Limited in December 2019. Aidigong Maternal & Child Health Limited is based in Kowloon Bay, Hong Kong.
URL
http://www.aidigong.hk/
IPO date
Sep 07, 1990
Employees
1,581
Domiciled in
HK
Incorporated in
BM

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
554,581
-21.15%
703,354
6.05%
663,235
6.91%
Cost of revenue
690,735
850,682
608,061
Unusual Expense (Income)
NOPBT
(136,154)
(147,328)
55,174
NOPBT Margin
8.32%
Operating Taxes
13,079
(21,141)
18,624
Tax Rate
33.76%
NOPAT
(149,233)
(126,187)
36,550
Net income
(177,421)
7.32%
(165,324)
-3,219.32%
5,300
-101.39%
Dividends
Dividend yield
Proceeds from repurchase of equity
(1,265)
(2,746)
317,259
BB yield
Debt
Debt current
171,431
189,919
279,715
Long-term debt
889,832
688,596
1,006,812
Deferred revenue
156,321
211,162
Other long-term liabilities
(310,169)
(378,686)
Net debt
959,247
769,136
1,107,514
Cash flow
Cash from operating activities
82,691
35,283
41,013
CAPEX
(36,369)
(37,354)
(24,770)
Cash from investing activities
(10,482)
(19,130)
(191,028)
Cash from financing activities
(45,027)
(43,117)
153,603
FCF
(368,577)
(126,067)
(110,548)
Balance
Cash
100,312
107,969
156,971
Long term investments
1,704
1,410
22,042
Excess cash
74,287
74,211
145,851
Stockholders' equity
(607,373)
(407,894)
(58,860)
Invested Capital
2,195,680
2,205,825
2,580,951
ROIC
1.52%
ROCE
2.05%
EV
Common stock shares outstanding
5,020,270
124,182
117,301
Price
Market cap
EV
EBITDA
43,000
49,845
201,310
EV/EBITDA
Interest
53,768
84,007
88,500
Interest/NOPBT
160.40%